Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
entire market is taking a dump. Dow off 618.
Would like to see the buying come back in toward the close. $1.70 close would be a good trend indicator on my charts.
The ultimate short squeeze paradox. Now GME is valued 23 Billion, and it is clearly not worth that. And, now would be the time to short it but you cannot get shares to short! 50% interest to short if you can find shares. I would bet most hedgies got crushed, called and are mostly out of their positions. Now what? A simple free fall of profit taking?
I hope some of the CVM guys take their profits and come back into NWBO!
Wow, CVM started trading again at $35/share.
I do. It has been in a downward trend for several weeks. Today it should change trend.
Wow. CVM, with a reported 27% short on outstanding shares is up 120% on 2.5 million shares. Only 39.8 million outstanding and less in float. Epic squeeze. We, unfortunately are not in the same boat with 900 million outstanding and a lot of that in the float. But, we can dream, and on positive topline, who knows!
Neither the Boyton option gift to a trust nor the auditor change have anything to do with delaying a potential buyout. They are irrelevant to any potential buyout.
I don’t think we would see a price jump in anticipation of an 8k filing. Most would think we did another financing which would usually drop the price. The next news is topline and then journal. This is a nothing burger. Marcum wasn’t able to resolve the German tax issue, had to restate something from earlier in the year and was late on the 10q. Sounds like they were fired.
Hopefully this is more than a technical correction and there is news this week.
Trying hard to knock it down toward close.
Impressive takedown of $1.50! Over 150,000 shares quickly. See if it holds.
Wow, chipping away at it, down to 35,000 on ask.
big resistance at $1.50, they've seen enough for today. Would just like to close at the high of the day and build from there tomorrow.
Would be nice to see a green, fully-engulfing hammer doji for the end of today.....need a nice reversal signal.
FeMike, your buddy Joe Pratt's video on NWBO now has 2300 views. Doesn't seem to be helping the PPS.
Yes we did, we had a video recommendation for NWBO by a defrocked stockbroker with 7 followers!
looks like it.
Any chance you commented or asked him where he gets his one-to-two week publication prediction from?
He works out of his house outside of Philly. Manages no money.
Yes, but he started his advisory service last year, has very few followers, not sure how many paid subscribers. NWBO is his biggest winner, lol. Look at his "model" portfolio performers, most are down. Glad he likes NWBO, but zero influence, IMO.
Or it will be a homerun. It is almost statistically impossible for the placebo group to outperform historical survival rates. It has never happened. So, the blended, blinded data will get better once separated and analyzed. The question is how much better. I just want to see the F'in data already.
Where would this guy get that info? One to two weeks? Would be great but I would say his guess is as good as anyone's here.
I think we get notice of ASM this week. LP needs to get approvals to raise authorized shares and raise money.
Another week of treading water. 110 days past data lock.
Not sure about PPS being held here, maybe accumulation. A $1.2 Billion valuation tells me the street is betting on something positive out of topline. That's all I can guess. Don't see anything meaningful in share appreciation until news.
Take it for what it's worth, or discard it, doesn't matter to me. I actually do not have a great relationship with IR, it is in fact very contentious. Last post was not an email, it was a phone conversation so nothing to copy and paste. Just happens to be the best I can offer in terms of the delay of topline. And, for the record, I think it should have been PR'd by now.
As one of the loudest critics of the company gameplan, or what little we know of it, I am very confident of the trial success. I am 100% confident the company has been unblinded for over two months and the SAB, steering committee and trial leaders (LL, AB, MB) are pouring through the data. They may be done with initial review and may even have topline PR complete and are waiting for Journal acceptance. The one thing I agree with and understand is what DI said to me (paraphrasing): These are scientists, they have no concern over share price or timing, they are interested in the science, there is nothing we can do to rush them because shareholders are impatient. I am confident that the Journal acceptance timing will indicate the magnitude of the success. Sooner means it's great data. The longer it takes, the more I believe they have to "sell" the nuance of the data rather than easily seen statistical significance of endpoints being met. Anything after March 1st topline will have me worried. JMHO.
Either a mistake on order to buy or a target gap to fill by EOD. Who knows. Still low volume and resistance at $1.45. I was hoping the wide bid/ask gap this morning was in preparation for wild trading. One can hope. But, I think we are a few months away from Journal so hoping for topline by mid-february.
Sorry, you have to reply to one thing:
What does this mean?
"For the matter, those that don't think we will have data this year, stand in line."
??? There was a trade at $1.59 at the open. Very Strange. Looks like 10,000 shares, then it dropped right back. Someone probably entered a buy limit order incorrectly, lol.
What's up with the $1.59 buy?
Yes, and at the risk of being deleted, but some off-topic posts stay until someone rebutts. I'm here for topline and that's what I would like to read about. We need to push through and hold $1.50 on much heavier volume for any retest of recent highs. Unfortunately, I doubt we see that without news and it seems the strategy for topline is locked into a Journal piece and that timeline is a huge unknown.
You said: But the issue is whether this transaction proves he/they are not in possession of tld??
Since there was no sale, and this was a non-arms length transaction from himself to himself/family (I assume), I do not believe it proved one way or another.
If he had sold shares, then I would say no, he is not in possession of TLD.
Insider trading rules would, I imagine. I am pretty sure trust rules apply to the beneficiaries and management officers/fiduciaries. He could have exercised and sold last week before he gifted to the trust as long as he was not in possession of material non-public information. We have had no insider sales, planned or otherwise. That, to me, is good news.
Of course, exercise price of .25, so right now, worth about $4.5 million. However, if topline isn't what I expect, they will be worthless. If it is hugely positive, he can use funds already in the trust to exercise and keep it all under one protected roof, so to speak. Just think it is more of a positive sign than anything else. Nothing as far as indication of topline timing though, IMO.
I would guess Dr. Boynton has other assets and this is a comprehensive strategy, as trust planning usually is. So, he could either be moving worthless options into the trust because he is already paying the planners, OR, he believes they have significant value and wants them moved before they realize that value.
Yes, but the only way we don't fill gaps up is if there is continued buying and either leak or news....I think so many people have their hands on the data there have to be some leaks....
Moving options into a trust has nothing to do with holding material info or not, IMO. Could be exact same beneficiary with expanded trust options and tax protection.